The FINANCIAL — Teva Pharmaceutical Industries Ltd. announced on August 7 that the U.S. Food and Drug Administration (FDA) has approved QVAR RediHaler (beclomethasone dipropionate HFA) inhalation ...

Please provide your email address to receive an email when new articles are posted on . Teva Pharmaceuticals announced that the FDA approved QVAR RediHaler inhalation aerosol for the prophylactic ...

Qvar RediHaler (beclomethasone dipropionate HFA) Inhalation Aerosol is a breath-actuated inhaled prescription medicine used as a maintenance treatment for the prevention and control of asthma in ...

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the use of QVAR® (beclomethasone dipropionate ...

First and Only Breath-Actuated Aerosol Inhaled Corticosteroid in the United States Designed to Help Eliminate the Need for Hand-Breath Coordination JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical ...

Beclomethasone dipropionate HFA inhalation aerosol is a corticosteroid indicated for the maintenance treatment of asthma as prophylactic therapy. “Our first metered-dose inhalation product is a ...

BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has tentatively approved ...

The particle size distribution of QVAR was measured using the Andersen cascade impactor (series 20-800 Mark II, Ecomesure, Janvry, France) operating at 28.3 L/min. The endotracheal tube was connected ...

Objective: To assess the bioequivalence of beclomethasone dipropionate (BDP) delivered from a press-and-breathe (PB) inhaler and a breath-actuated inhaler (Autohaler TM, AH). Design: Two randomised, ...